How EVO ICL Is Shaping the Future at My-iClinic

STAAR Surgical UK & Ireland is proud to announce the success of its recent EVO ICL User Summit, where leading eye surgeons and vision correction specialists gathered to discuss the future of Implantable Collamer Lens (ICL) technology in the UK and Ireland.

Among the respected attendees was Bola Odufuwa-Bolger, a highly regarded eye surgeon and Medical Director at My-iClinic in London, whose contributions helped elevate the discussions throughout the event. Bola shared valuable clinical insights and expressed her growing confidence in the STAAR Surgical EVO ICL platform:

“I can now safely offer many more people ICL surgery — from those with very low prescriptions to those with significantly high ones,” said Bola during one of the summit’s open forums.

The summit brought together experienced and emerging EVO ICL users to share best practices, explore the evolving treatment landscape, and discuss STAAR’s commitment to innovation. With a growing number of patients seeking alternatives to glasses and contact lenses, the role of ICL in modern vision correction continues to gain momentum.

Highlights Of The Day

Bola Odufuwa-Bolger and John Bolger found the EVO ICL User Summit both inspiring and forward-looking. Surrounded by like-minded peers and industry innovators, they engaged in valuable discussions around the expanding role of ICL in modern refractive surgery. For Bola, a standout moment was recognising how EVO ICL now safely opens the door to treatment for a wider group of patients — from those with very low prescriptions to those with extremely high ones. John reflected on the shift in patient attitudes, noting how more individuals are actively seeking safe, reversible alternatives to laser-based procedures. Together, they shared insights with fellow clinicians on the evolving expectations of today’s vision correction patients and the importance of personalised treatment strategies.

The summit further solidified My-iClinic’s commitment to staying at the forefront of refractive innovation. With renewed confidence in the EVO ICL platform, both Bola and John left the event energised to integrate these learnings into daily practice. From enhanced patient selection to offering premium lens-based solutions as a first-choice treatment, the clinic is now even better positioned to serve patients seeking high-quality, long-term vision correction. As Bola put it, the event “confirmed that the future of vision correction is here — and it’s one we’re proud to offer.”

About STAAR Surgical

STAAR Surgical is a global developer and manufacturer of implantable lenses and companion delivery systems for the eye. Its EVO ICL™ family of lenses is designed to correct a wide range of refractive errors, offering patients high-definition vision without removing corneal tissue. With millions of lenses implanted worldwide, STAAR continues to be a leader in premium refractive solutions.

To learn more, visit: www.staar.com